Awarded

Médicament radiopharmaceutique fluoré indiqué pour l'imagerie en TEP des plaques amyloides

Original language: French

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Contract value
no value published
Bids received
2
Published
2 Jul 2026
Awarded
11 May 2026
Contract start
11 May 2026
Contract end
28 May 2027estimated
Region
Savoie

More awards from this buyer

Médicament radiopharmaceutique fluoré indiqué pour l'imagerie en TEP des plaques amyloides — GE HEALTHCARE SAS · Adjudera